NIH Schedules Closed Grant Review Meetings for July
Published Date: 6/5/2026
Notice
Summary
The Center for Scientific Review at the NIH is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for exciting science projects. If you’re involved in cell biology, heart disease, mental health, or cancer research, these reviews could impact your funding timeline and opportunities.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
NIH peer-review meetings July 8–10
The NIH Center for Scientific Review will hold multiple closed virtual meetings on July 8–10, 2026 to review and evaluate grant applications. Panels include areas such as cell biology, cardiovascular biology and disease, mental health/addiction, cancer management and treatment, HIV and infectious disease studies, R35 investigator awards, fellowships, and research career development — these reviews decide funding and can affect applicants' funding timelines or opportunities.
Meetings closed to protect IP and privacy
The meetings will be closed to the public under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, commercial property such as patentable material, and personal information of individuals associated with grant applications. This prevents public disclosure of applicants' proprietary information during the review process.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-18877, Prospective Grant of an Exclusive Patent License: Development and Commercialization of Engineered Cell Therapies for the Treatment of HPV 16 E6-Expressing Cancers
The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the patents and patent applications listed in the Supplementary Information section of this notice to MedGene Therapeutics, Inc. ("MedGene"), a company located in Silver Spring, Maryland, the United States of America.
2026-18646, Draft NIH Biosafety Policy for Research Involving Biohazards
The NIH is updating its biosafety rules to keep research safe as science changes and grows. This new policy will replace old guidelines and affect anyone working with biohazards in NIH-funded research. They want your thoughts by October 19, 2026, to help shape these important safety updates without adding extra costs.
2026-18191, Submission for OMB Review; 30-Day Comment Request Data and Specimen Hub (DASH) (Eunice Kennedy Shriver National Institute of Child Health and Human Development)
The National Institutes of Health (NIH) is asking for public feedback on their Data and Specimen Hub (DASH), which helps researchers share important health data. This is a quick 30-day review to make sure the information collection is clear and useful. If you’re involved in health research or data sharing, your input by October 8, 2026, can help shape how DASH works without costing extra money or time.
2026-17899, Proposed Collection; 60-Day Comment Request; Assurance (Interinstitutional, Foreign, and Domestic) and Annual Report (Office of the Director)
The NIH wants your thoughts on their plan to keep track of animal research safety through yearly reports and assurances from institutions, both in the U.S. and abroad. This helps make sure labs follow the rules and protect animals, with no new costs or big changes expected. You’ve got until October 2, 2026, to share your feedback and help improve the process!
2026-17687, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in October 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, ensuring fair and confidential decisions. Scientists applying for grants in genetics, molecular sciences, oral health, and cancer research are the ones affected, with no direct cost changes announced.
2026-17438, Center For Scientific Review; Notice of Closed Meetings
The NIH's Center for Scientific Review is holding several closed virtual meetings in late September 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, affecting researchers applying for funding. No direct money changes are announced, but these reviews decide who gets research grants.
Previous / Next Documents
Previous: 2026-11365, Ealytex Global Inc., Complainant v. COSCO Shipping Lines Co., Ltd., Respondent; Notice of Filing of Complaint and Assignment
Ealytex Global Inc. is officially complaining against COSCO Shipping Lines for charging unfair fees when Ealytex couldn’t move their containers on time. COSCO has 25 days to respond, and a final decision will come by the end of 2027. This affects businesses relying on shipping and could change how detention fees are handled, possibly saving money for shippers.
Next: 2026-11368, Chromium Trioxide From India and Turkey; Scheduling of the Final Phase of Countervailing Duty and Antidumping Duty Investigations
The U.S. is taking a close look at imports of chromium trioxide from India and Turkey to see if they're hurting American businesses by being sold too cheaply or unfairly supported by the Indian government. This investigation could lead to extra taxes on these imports to protect U.S. industries. The final decision phase started on May 22, 2026, so changes might be coming soon for importers and buyers.